Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Mondaycom Ltd (MNDY) Price & Performance

Heron Therapeutics IncTrade
Mondaycom LtdTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Mondaycom Ltd — how do they compare? Heron Therapeutics Inc trades at $0.34 (market cap $61.47M), while Mondaycom Ltd trades at $84.33 (market cap $3.70B). The key difference: Mondaycom Ltd is far larger — about 60.2× Heron Therapeutics Inc's market cap, and Mondaycom Ltd is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXMNDY
Market Cap
$61.47M$3.70B
Sector
HealthTechnology
52-Week High
$1.49$219.15
52-Week Low
$0.32$58.81
Enterprise Value
$168.21M$2.86B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.

The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.

Mondaycom Ltd

Monday.com (MNDY) trades at $84.4, down 4.76% amid mixed signals. The stock shows strong fundamentals with Q2 2026 EPS of $1.48 beating estimates by 33%, revenue growth of 22% year-over-year, and a high gross margin of 88.74%. However, weak Q3 revenue guidance has triggered a sell-off. Technical indicators are neutral with support at $83 and resistance at $89. Analyst consensus remains bullish with a $113.38 price target, but near-term volatility persists due to growth concerns.

The outlook is cautiously optimistic given solid earnings beats and AI product traction, but investor sentiment is tempered by slowing revenue guidance. Key risks include SaaS sector pressures and execution challenges in shifting to enterprise AI. Upside potential exists if the company exceeds Q3 expectations, though volatility may continue until growth reaccelerates.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Mondaycom Ltd

Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.

Read more on MNDY